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Abstract
Background: Whole cell-catalyzed biotransformation is a clear process option for the production
of chiral alcohols via enantioselective reduction of precursor ketones. A wide variety of
synthetically useful reductases are expressed heterologously in Escherichia coli to a high level of
activity. Therefore, this microbe has become a prime system for carrying out whole-cell
bioreductions at different scales. The limited capacity of central metabolic pathways in E. coli usually
requires that reductase coenzyme in the form of NADPH or NADH be regenerated through a
suitable oxidation reaction catalyzed by a second NADP+ or NAD+ dependent dehydrogenase that
is co-expressed. Candida tenuis xylose reductase (CtXR) was previously shown to promote NADH
dependent reduction of aromatic α-keto esters with high Prelog-type stereoselectivity. We
describe here the development of a new whole-cell biocatalyst that is based on an E. coli strain co-
expressing CtXR and formate dehydrogenase from Candida boidinii (CbFDH). The bacterial system
was evaluated for the synthesis of ethyl R-4-cyanomandelate under different process conditions and
benchmarked against a previously described catalyst derived from Saccharomyces cerevisiae
expressing CtXR.
Results:  Gene co-expression from a pETDuet-1 vector yielded about 260 and 90 units of
intracellular CtXR and CbFDH activity per gram of dry E. coli cell mass (gCDW). The maximum
conversion rate (rS) for ethyl 4-cyanobenzoylformate by intact or polymyxin B sulphate-
permeabilized cells was similar (2 mmol/gCDWh), suggesting that the activity of CbFDH was partly
rate-limiting overall. Uncatalyzed ester hydrolysis in substrate as well as inactivation of CtXR and
CbFDH in the presence of the α-keto ester constituted major restrictions to the yield of alcohol
product. Using optimized reaction conditions (100 mM substrate; 40 gCDW/L), we obtained ethyl
R-4-cyanomandelate with an enantiomeric excess (e.e.) of 97.2% in a yield of 82%. By increasing the
substrate concentration to 500 mM, the e.e. could be enhanced to ≅100%, however, at the cost of
a 3-fold decreased yield. A recombinant strain of S. cerevisiae converted 100 mM substrate to 45
mM ethyl R-4-cyanomandelate with an e.e. of ≥ 99.9%. Modifications to the recombinant E. coli (cell
permeabilisation; addition of exogenous NAD+) and addition of a water immiscible solvent (e.g.
hexane or 1-butyl-3-methylimidazolium hexafluorophosphate) were not useful. To enhance the
overall capacity for NADH regeneration in the system, we supplemented the original biocatalyst
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after permeabilisation with also permeabilised E. coli cells that expressed solely CbFDH (410 U/
gCDW). The positive effect on yield (18% → 62%; 100 mM substrate) caused by a change in the ratio
of FDH to XR activity from 2 to 20 was invalidated by a corresponding loss in product enantiomeric
purity from 86% to only 71%.
Conclusion: A whole-cell system based on E. coli co-expressing CtXR and CbFDH is a powerful
and surprisingly robust biocatalyst for the synthesis of ethyl R-4-cyanomandelate in high optical
purity and yield. A clear requirement for further optimization of the specific productivity of the
biocatalyst is to remove the kinetic bottleneck of NADH regeneration through enhancement (≥
10-fold) of the intracellular level of FDH activity.
Background
Enzyme-catalyzed enantioselective reductions of ketones
have become quite popular for the production of homo-
chiral alcohols at industrial scale [1]. NAD(P)H-depend-
ent reductases catalyze these transformations with
exquisite chemo-, regio-, and stereoselectivities such that
usually an optically pure product is obtained in high
yield. Generally, the biocatalyst employed for ketone
reduction can be a whole-cell system or a (partially) puri-
fied protein preparation [2-5]. The use of whole cells
offers the important advantage of a simple, hence low-
cost catalyst preparation. The synthetic reductase is often-
times more stable within the cellular environment as
compared to the isolated enzyme. Enzymatic reduction of
ketones is usually performed in the presence of a substoi-
chiometric amount of coenzyme (NADH or NADPH),
implying that the catalytic reductant must be recycled dur-
ing the conversion. Cells provide a basal capacity for coen-
zyme regeneration through the reduction of NAD+ and
NADP+ in central metabolic pathways. The spatial organi-
sation of the whole-cell system where enzymes and cofac-
tors are encapsulated by the supramolecular structure of
the cell membranes potentially improves the efficiency of
coenzyme recycling as compared to homogeneous reac-
tors employing "free-floating" biocatalytic components.
Considering the ability of Escherichia coli to over-express
various synthetically useful ketoreductases to a high level
of activity, this organism has become a prime choice for
the development of whole-cell bioreduction catalysts. The
capabilities of E. coli to provide internal cofactor regener-
ation are, however, oftentimes limiting overall [6-9]. Co-
expression of another, NAD+ or NADP+-dependent dehy-
drogenase is therefore used to couple the biosynthetic
reduction of the target ketone with the oxidation of a suit-
able co-substrate. Currently, oxidation of glucose cata-
lyzed by glucose dehydrogenase (GDH) is most often
used for cofactor regeneration [2,6,9-14]. While the
method effectively drives ketone reduction and can be
flexibly applied to the recycling of NADH and NADPH,
there is the clear disadvantage that the native glucose
uptake system in E. coli involves coupled transport and
phosphorylation. The resulting glucose 6-phosphate is
not a substrate of GDH. To provide glucose efficiently for
GDH-catalyzed oxidation, one must therefore make the
cell membrane just sufficiently permeable for glucose (but
not for coenzyme) or engineer the glucose uptake system
[15-17]. Formation of gluconic acid as the ultimate oxida-
tion product that is not further used in the reaction has a
negative impact on the atom economy of the overall con-
version. Moreover it requires that bioprocessing be per-
formed under pH control [6,11,12,14,17]. Addition of
concentrated base can lead to local peaks of high pH in
imperfectly mixed bioreactors which in turn constitutes a
strong factor of enzyme inactivation [18-20]. The use of
GDH was further invalidated in this work because the
ketoreductase employed for synthesis showed weak activ-
ity towards reduction of glucose into sorbitol [21].
Therefore, the ideal co-substrate should be readily taken
up by the E. coli cell. It should not by itself or the product
generated from it, inhibit or inactivate the synthetic
ketoreductase. Oxidation of the co-substrate should be
thermodynamically favoured, and the co-product should
be easily removed from the reaction mixture. These
demands are widely met by the conversion of formate into
carbon dioxide catalyzed by formate dehydrogenase
(FDH) [7,17,22-26]. FDH enzymes from yeast and bacte-
rial sources are typically specific for NAD+ and can be used
in a broad pH range (pH 6.0–9.0; [27]). While many
papers have been published on the use of isolated FDH
for the regeneration of NADH, particularly the enzyme
from Candida boidinii (CbFDH), the development of cor-
responding whole-cell systems is not advancing as
quickly. The relatively low specific activity of CbFDH (3
U/mg, [28]) is considered a drawback for whole-cell
applications of this enzyme.
We describe in this paper the construction of a novel
whole-cell biocatalyst that was derived from E. coli BL21
(DE3) through co-expression of the genes encoding Can-
dida tenuis xylose reductase (CtXR) and CbFDH. It was
shown in previous work that CtXR promotes the reduc-
tion of aromatic α-keto esters with useful efficiency and
excellent stereoselectivity [29]. Here, the synthesis of ethyl
R-4-cyanomandelate was employed to characterize andMicrobial Cell Factories 2008, 7:37 http://www.microbialcellfactories.com/content/7/1/37
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optimize the biocatalytic performance of the recombinant
E. coli strain (Figure 1). The bacterial whole-cell system
was compared with a recently developed strain of Saccha-
romyces cerevisiae that was designed for stereospecific
reduction of aromatic α-keto esters through overexpres-
sion of the gene encoding CtXR.
Results and discussion
Co-expression of CtXR and CbFDH in E. coli
The vector pETDuet-1-XR_FDH was constructed to enable
co-expression of the genes encoding CtXR and CbFDH.
The specific activity of purified CbFDH (3 U/mg; [28]) is
about 2-fold that of the purified CtXR on 10 mM ethyl 4-
cyanobenzoylformate (1.8 U/mg). We placed the gene
encoding CbFDH after the CtXR gene with the aim of spe-
cifically enhancing the overproduction of the formate
dehydrogenase, as recommended by the supplier Nova-
gen.
In a screening for conditions that are suitable for the
simultaneous production of CtXR and CbFDH in E. coli
BL21 (DE3), we compared low (0.25 mM) and high (1.00
mM) IPTG concentrations in combination with short (5
h) and long (20 h) induction times. The specific activity of
CtXR in the cell-free extract was not dependent on the
IPTG concentration but enhanced from 0.58 U/mg to
0.91 U/mg by using the long induction phase. The specific
activity of CbFDH (0.18 U/mg) was insensitive to changes
in any of the two cultivation parameters. By way of com-
parison, the specific activity of CbFDH in the cell extract of
E. coli FDH was 1.4 U/mg. The specific activity of CtXR in
E. coli XR_FDH compares roughly to one of 0.49 U/mg
that is obtained when using the expression vector pBE-
Act.1i in E. coli BL21 (DE3). The results also show that the
activity ratio CtXR/CbFDH in E. coli XR_FDH was ~8-fold
higher than expected from the specific activities of the
purified enzymes. Therefore, differential overproduction
of CtXR and CbFDH to favour formation of the formate
dehydrogenase did not occur with the expression con-
struct used. We inspected E. coli XR_FDH under the light
microscope and observed that a substantial amount of
protein inclusion bodies was formed under induction
conditions (data not shown). While intracellular precipi-
tation could clearly account for losses of CbFDH activity,
we considered the examination of folding factors for
CbFDH in E. coli to be outside the scope of this paper. The
level of CbFDH expression using pETDuet-1-XR_FDH was
comparable to that seen in previous work where CbFDH
and an alcohol dehydrogenase were co-expressed in E. coli
BL21 (DE3) from a pACYCDuet-1 vector [23]. Note that
the arrangement of genes in the expression construct was
similar in both studies.
Table 1 summarizes results of activity measurement for E.
coli  XR_FDH. To facilitate the comparison of different
whole-cell catalysts, we normalized the results using gCDW.
The activity of CtXR (using xylose as the substrate) in E.
coli XR_FDH was about 7 times the corresponding enzyme
activity in S. cerevisiae XR2μ. The levels of the enzyme
activities exploited in the regeneration of NADH were
similar in E. coli XR_FDH and S. cerevisiae XR2μ (alcohol
dehydrogenase; ADH). With the assay used [30], the level
of NAD+-dependent aldehyde dehydrogenase (AlDH)
activity in S. cerevisiae XR2μ was below detection limit (<
0.2 U/gCDW). The wild-type strain of S. cerevisiae as well as
E. coli FDH shows no ethyl 4-cyanobenzoylformate
reductase activity in the absence of CtXR overexpression.
Whole cell-catalyzed reduction of ethyl 4-
cyanobenzoylformate
We compared the initial rates of substrate reduction (rS)
by E. coli XR_FDH, S. cerevisiae XR2μ, and the wild-type
strain of S. cerevisiae. A low substrate concentration of 10
mM was chosen to decrease toxic effects of ethyl 4-
cyanobenzoylformate on the cells (see later). Yeast biore-
duction experiments were carried out under anaerobic
Whole-cell biocatalytic reduction of ethyl 4-cyanobenzoylformate using a recombinant strain of E. coli co-expressing Candida  tenuis xylose reductase (CtXR) and Candida boidinii formate dehydrogenase (CbFDH) Figure 1
Whole-cell biocatalytic reduction of ethyl 4-cyanobenzoylformate using a recombinant strain of E. coli co-
expressing Candida tenuis xylose reductase (CtXR) and Candida boidinii formate dehydrogenase (CbFDH).Microbial Cell Factories 2008, 7:37 http://www.microbialcellfactories.com/content/7/1/37
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conditions in the presence of ethanol as co-substrate to
promote ADH-catalyzed regeneration of NADH while
suppressing at the same time routes that could recycle
NADPH. Kratzer et al. [31] have recently shown that
reduction of aromatic α-keto esters by S. cerevisiae XR2μ
proceeded under these conditions with the near perfect
enantioselectivity of isolated CtXR in analogous conver-
sions. Initial rates (rS) were calculated from linear time
courses of substrate conversion in the first ≅ 1 h of reac-
tion, and results are summarized in Table 2. rS-Values for
the bacterial strain and S. cerevisiae XR2μ were similar and
surpassed that for the wild-type yeast by a factor of 10. The
comparison of data in Tables 1 and 2 reveals that the
observed pattern of rS values is not reflected clearly in the
activity levels for the biosynthetic and NADH-regenerat-
ing enzymes that are present in the different cells. How-
ever, we must consider that rS is a kinetically complex
parameter (Figure 1) that is also prone to mass transfer
effects.
The e.e. of the alcohol product obtained by using E. coli
XR_FDH was reasonable but not as good as in bioreduc-
tions with S. cerevisiae XR2μ or the isolated CtXR (Table 2,
[29,31]). This result and evidence presented later indicate
that in contrast to the widely held notion [6,7] the effect
of the E. coli reductase background must not generally be
neglected during development of a whole-cell catalyst for
reduction of ketones [6,9,14]. The stereochemical out-
come of the conversion of ethyl 4-cyanobenzoylformate
by E. coli XR_FDH, however, presented a clear improve-
ment in terms of selectivity as compared to reduction of
the same substrate by the wild-type strain of S. cerevisiae.
Table 2 also shows the effect of varied substrate and cell
concentrations on rS for E. coli XR_FDH. At a given con-
centration of ethyl 4-cyanobenzoylformate, rS was largely
independent of the cell concentration used in the experi-
ment. rS was doubled in response to an increase in sub-
strate concentration from 10 mM to 100 mM. However, as
the solubility of ethyl 4-cyanobenzoylformate was only
around 10 mM under the conditions used, the availability
Table 1: Biosynthetic and NADH regenerating enzyme activities in different strains of E. coli and S. cerevisiae
strain XR activity [U/gCDW]1 NADH-dependent dehydrogenase activity [U/gCDW]1 NADH+-dependent
E. coli XR_FDH 256 85 (FDH)
E. coli FDH 0 408 (FDH)
S. cerevisiae XR2μ 35 174 (ADH)
S. cerevisiae wild-type 0 112 (ADH)
1Standard errors ≤ 15%.
Table 2: Initial rates and ee-values of ethyl 4-cyanobenzoylformate reduction by different whole-cell biocatalysts.
strain cell dry weight [g/L] substrate conc. initial rate [mmol/g h]1/ee2 [%]
E. coli XR_FDH 5 10 0.60/97.0 R
E. coli XR_FDH 5 100 1.12/99.0 R
E. coli XR_FDH 20 100 1.39/99.3 R
E. coli XR_FDH 40 100 1.19/98.6 R
E. coli XR_FDH 40 500 1.94/99.9 R
S. cerevisiae XR2μ 3 51 0 0 . 2 6 / ≥ 99.9 R
S. cerevisiae XR2μ 3 40 100 1.03/≥ 99.9 R
S. cerevisiae wild-type3 5 10 0.06/80.4 R
1Determined from the time course of substrate conversion between 0 and ≤ 1.4 h reaction time; standard errors ≤ 20%. 2 The detection limit of 
ethyl 4-cyanomandelate is below 0.01 mM. 3Anaerobic reaction conditions where [O2] < 15 μM; ethanol was used as co-substrate.Microbial Cell Factories 2008, 7:37 http://www.microbialcellfactories.com/content/7/1/37
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of substrate at higher concentrations of the keto ester was
not clear. The 1.6-fold enhancement in rS resulting from
an increase in substrate concentration from 100 mM to
500 mM is interesting as it seems to imply uptake of ethyl
4-cyanobenzoylformate by the cells directly from the
organic phase. The concentration of substrate dissolved in
the aqueous phase will be the same irrespective of the
total substrate concentration being 100 mM or 500 mM.
Another important implication of Table 2 is that e.e.
increased as the substrate concentration was raised. The
level of substrate that was optimal with respect to maxi-
mizing the e.e. was dependent on the cell concentration
used. The results suggest that the E. coli reductase back-
ground which is responsible for the lowering of the opti-
cal purity of product was inhibited by high substrate
concentrations.
Figure 2 shows the full time courses of substrate conver-
sion by E. coli XR_FDH under the conditions that were
used for determination of initial rates in Table 2. In terms
of product yield based on substrate used in the overall
reaction, the choice of a cell concentration of 40 gcdw/L
and a substrate concentration of 100 mM was best and
used during further optimization of the whole-cell
biotransformation. However, the maximum yield
obtained in Figure 2 was significantly below 100%, mak-
ing it also necessary to examine the factors that limit con-
version of ethyl 4-cyanobenzoylformate into product.
Note that when using S. cerevisiae XR2μ (40 gCDW/L), the
yield from 100 mM ethyl 4-cyanobenzoylformate was
45% (data not shown).
Whole cell-catalyzed reduction of ethyl 4-cyanobenzoylformate by E. coli XR_FDH Figure 2
Whole cell-catalyzed reduction of ethyl 4-cyanobenzoylformate by E. coli XR_FDH. The analytical yield is given and 
expressed as concentration of ethyl 4-cyanomandelate formed from the initial substrate concentration. Conditions are indi-
cated by symbols: ● [substrate] = 500 mM, [cells] = 40 gCDW/L; ❍ [substrate] = 100 mM, [cells] = 40 gCDW/L; ▲ [substrate] = 
100 mM, [cells] = 20 gCDW/L; Δ [substrate] = 100 mM, [cells] = 5 gCDW/L; ■ [substrate] = 10 mM, [cells] = 5 gCDW/L.
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Limitations in whole-cell reductions of ethyl 4-
cyanobenzoylformate by E. coli XR_FDH and S. 
cerevisiae XR2μ
Time courses of reduction of ethyl 4-cyanobenzoylfor-
mate were characterized by a sharp decrease in the conver-
sion rate which irrespective of the amount of product
already formed under the different experimental condi-
tions, occurred at approximately the same time during the
initial phase of the transformation (Figure 2). Chemical
degradation of substrate and/or product and deactivation
of XR and/or enzymes involved in coenzyme regeneration
are factors that could account for the observed slowing
down of the reaction and hence limit the final yield of
alcohol product (Figure 3). We incubated 100 mM ethyl
4-cyanobenzoylformate identically as in Figure 2 but in
the absence of biomass as a control and measured sponta-
neous decomposition of the substrate [32], which is most
probably due to hydrolysis (Figure 3). Ethyl 4-cyanoben-
zoylformate was quite unstable, its calculated half-life
time being only about 1.4 h. No detectable degradation of
the product ethyl 4-cyanomandelate took place under the
same conditions during a 6-h long incubation (data not
shown). The presence of the α-keto ester substrate (100
mM) had a strong negative impact on the stabilities of XR
and FDH in E. coli XR_FDH cells, as shown in Figure 3.
The calculated half-life time of XR was 1.4 h, that of FDH
was 1.5 h. In the absence of substrate, the two enzymes
were fully stable over the period of 6 hs [28]. Therefore,
these results imply that reduction of ethyl 4-cyanoben-
zoylformate is critically limited by substrate as well as bio-
catalyst stability. In order to obtain high product yield, it
would thus be necessary that rS is much larger throughout
Inactivation of enzymes and spontaneous decomposition of substrate are limiting factors during whole cell-catalyzed reduction  of ethyl 4-cyanobenzoylformate by E. coli XR_FDH Figure 3
Inactivation of enzymes and spontaneous decomposition of substrate are limiting factors during whole cell-
catalyzed reduction of ethyl 4-cyanobenzoylformate by E. coli XR_FDH. Inactivation: E. coli XR_FDH (40 gCDW/L) 
was incubated in the presence of 100 mM ethyl 4-cyanobenzoylformate and at the indicated times, enzyme activities were 
measured after cell disruption using B-Per (❍ CtXR activity, ▲ CbFDH activity). Substrate decomposition: 100 mM ethyl 4-
cyanobenzoylformate was incubated in potassium phosphate buffer 50 mM, pH 7.5, lacking cells, and the concentration of the 
compound was measured by HPLC in samples taken at the indicated times (●).
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than the decomposition rate of the substrate. Likewise,
unless stabilized against inactivation by the organic sub-
strate, cells cannot be re-used for multiple rounds of
batchwise substrate conversion. Feeding the substrate at a
moderately toxic concentration [33] and the use of less
toxic organic co-solvents (see later) might be relevant
process options with which to enhance both substrate uti-
lization and the total turnover number of the enzymes.
The development of a fed-batch process was beyond the
scope of this paper.
The half-life time of XR in S. cerevisiae XR2μ was 2.7 h, a ≅
2-fold increase in enzyme stability as compared to the E.
coli XR_FDH system. According to literature [34] baker's
yeast is more resistant than E. coli to the denaturing effects
of organic compounds, irrespective of whether they are
soluble or present as a second liquid phase. Therefore, this
could explain the observed stabilisation of XR. Note that
a soluble preparation of XR has a half-life time of 3.7 min
when exposed to 100 mM ethyl 4-cyanobenzoylformate,
indicating that the whole-cell environment of S. cerevisiae
or E. coli generally provides significant protection to the
enzyme. However, with a half-life of only 0.8 h, the stabil-
ity of ADH appeared to determine overall lifetime of the
yeast whole-cell catalyst under the conditions used for α-
keto ester reduction.
Effect of organic co-solvents on ethyl 4-
cyanobenzoylformate reduction
We considered that a water-immiscible organic co-solvent
could, by lowering the substrate concentration in the
aqueous phase which contains the whole-cell catalyst,
improve the stability of all critical components in the reac-
tion system for ethyl 4-cyanobenzoylformate reduction. A
widely held notion is that the toxicity of organic solvents
on whole cells decreases as their logP value increases. We
therefore selected three common solvents covering a logP
range from 0.68 to 3.5 (ethyl acetate 0.68; butyl acetate
1.7; hexane 3.5) and one ionic liquid (1-butyl-3-methyl-
imidazolium hexafluorophosphate (BMIMPF6)). The
BMIMPF6 co-solvent was chosen considering the report of
Bräutigam et al. [22] where this ionic liquid was described
as biocompatible and not damaging to cells. Taking into
account the relevant literature (e.g. [22,35,36]), it was
unexpected that both E. coli XR_FDH (Table 3) and S. cer-
evisiae XR2μ (data not shown) displayed a significantly
poorer biocatalytic performance in the presence of co-sol-
vent than in the absence thereof. By way of comparison,
the use of BMIMPF6 caused ≅ 13-fold enhancement of
space-time-yield in the reductive conversion of a β-keto
ester catalyzed by whole cells of E. coli co-expressing a
ketoreductase and bacterial FDH [22]. Therefore, these
findings provide a note of caution concerning generalisa-
tion of the use of organic co-solvents for whole cell-cata-
lyzed reduction of ketones. They also emphasize that
despite the clear focus on E. coli and S. cerevisiae in the
development of whole-cell biocatalysts [13,37,38], there
remains the requirement for case-specific optimization of
reaction conditions by medium engineering.
Effect of cell permeabilization and externally added NAD+ 
on ethyl 4-cyanobenzoylformate reduction
Evidence from previous studies of ketone reduction by
whole-cell biocatalysts suggests that rS can in certain cases
be enhanced by making the cell wall more easily permea-
ble for low-molecular weight compounds such as sub-
strates, products and if applied, external NAD(P) cofactors
[10,39-43]. From the various methods reported for per-
meabilization of Gram-negative bacteria [44], we selected
treatment with the antibiotic polymyxin B sulphate
because of its mainly locally disruptive effect on cell wall
integrity. Polymyxin B sulphate binds to the lipid A por-
tion of bacterial lipopolysaccharides and induces pore for-
mation in the membrane [45]. Data in Table 3 shows that
the chosen permeabilization did not affect the perform-
ance of E. coli XR_FDH in the conversion of ethyl 4-
cyanobenzoylformate. Likewise, the addition of NAD+
(see [6,13,23]) to intact or polymyxin B sulphate-treated
cells of E. coli XR_FDH did not enhance the product yield
in reactions performed in aqueous buffer. Under condi-
tions where an organic co-solvent or BMIMPF6  was
present, however, the yield was improved up to 9-fold as
result of supplementation of the medium with external
NAD+. Summarizing, the highest yield (≅80%) of ethyl R-
4-cyanomandelate from 100 mM substrate was obtained
when using aqueous buffer lacking co-solvents and other
additives. Note that conversion of the α-keto ester via
enzymatic reduction and the competing route of chemical
decomposition was complete in all experiments, implying
that ≥ 20% of the used substrate was lost to non-enzy-
matic transformations. The absence of a rate-enhancing
effect of external NAD+ may be explicable on account of
the total intracellular concentration of NAD(H) which is
around 1 mM [46]. Considering the Km values of CtXR
[47] and CbFDH [23] for NADH and NAD+ which are 38
μM and 90 μM, respectively, it seems probable that the
levels of reduced and oxidized coenzyme in E. coli are high
enough to saturate the coupled enzyme system. Permeabi-
lization of S. cerevisiae XR2μ was not pursued.
Evidence for limitation of rS by the activity of FDH
E. coli XR_FDH showed a XR to FDH activity ratio of 3:1,
which may not be optimal for biocatalytic synthesis. The
level of FDH activity in E. coli FDH was 5 times that of E.
coli XR_FDH (Table 1). We therefore used E. coli FDH to
complement the possible deficit of E. coli XR_FDH with
respect to FDH activity. Experiments were performed at a
constant XR activity of 1.4 U/mL (equivalent to 5 gCDW/L
E. coli XR_FDH) and the activity of FDH was varied at lev-
els of 3, 9 and 27 U/mL. Both E. coli strains were permea-Microbial Cell Factories 2008, 7:37 http://www.microbialcellfactories.com/content/7/1/37
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bilized using polymyxin B sulphate, and external NAD+
was also added. Results are summarized in Table 4. They
show that product yield increased markedly (≅ 3.5-fold)
in response to a 10-fold increase in FDH activity, demon-
strating that rS of E. coli XR_FDH is limited by NADH
regeneration capacity. The presence of external NAD+ did
not stimulate rS in the two-strain system, indicating that it
is availability of NADH, however not that of total coen-
zyme that restricts the synthesis rate. Using a comparable
system where one E. coli strain expressed the synthetic
ketoreductase and another GDH for regeneration of
NADPH, Xu et al. [9] made the observation that the cellu-
lar pools of coenzyme are sufficient to promote ketone
reduction. Table 4 reveals that the optical purity of prod-
uct decreased significantly in response to an increase in
the total biomass concentration that was necessary to raise
the level of FDH, relative to that of XR, in the reaction. The
result provides a note of caution regarding the role of the
E. coli ketoreductase background in the overall conversion
of the ketone substrate (see also, [6,9,14].
Conclusion
A whole-cell system based on E. coli co-expressing CtXR
and CbFDH is a powerful biocatalyst for the synthesis of
ethyl R-4-cyanomandelate in high optical purity and use-
ful yield. The performance of the novel E. coli strain in the
conversion of 100 mM α-keto ester substrate surpassed
that of a yeast strain previously developed for chiral alco-
hol production using CtXR-catalyzed reduction [31].
Ethyl 4-cyanobenzoylformate was highly "toxic" to the
bacterial and yeast biocatalysts, causing rapid inactivation
of CtXR and CbFDH in E. coli and likewise, CtXR and ADH
in S. cerevisiae. In the absence of a suitable co-solvent that
alleviates the toxic effect, a fed-batch transformation
might be the most promising process option for each
strain. A clear requirement for further optimization of the
Table 3: Effect of additives and co-solvents on yield and enantiomeric excess of whole-cell bioreduction of ethyl 4-
cyanobenzoylformate catalyzed by E. coli XR_FDH.
substrate conc. [mM] org. co-solvent1 additive2,3 yield [mM]4/ee [%]5
100 82/97.2 R
100 NAD+ 85/97.1 R
100 polymyxin B 75/97.0 R
100 NAD+, polymyxin B 77/97.2 R
100 ethyl acetate 1/> 99.9 R
100 ethyl acetate NAD+ 9/> 99.9 R
100 hexane 3/> 99.9 R
100 hexane NAD+ 7/> 99.9 R
500 134/> 99.9 R
500 NAD+ 136/> 99.9 R
500 polymyxin B 125/> 99.9 R
500 NAD+, polymyxin B 126/> 99.9 R
500 butyl acetate 9/> 99.9 R
500 butyl acetate NAD+ 35/> 99.9 R
500 BMIMPF6 74/> 99.9 R
500 BMIMPF6 NAD+ 108/> 99.9 R
Conditions: 40 gCDW/L; 8.5 h reaction time. 1Co-solvents were added in 1:1 volume ratio. 2 [NAD+] = 490 μM. 3 [polymyxin B sulphate] = 144 μM. 
4Standard errors ≤ 15%. 5Detection limit of ethyl 4-cyanomandelate is below 0.01 mM.Microbial Cell Factories 2008, 7:37 http://www.microbialcellfactories.com/content/7/1/37
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specific productivity of the E. coli biocatalyst is to remove
the kinetic bottleneck of NADH regeneration through
enhancement (≥ 10-fold) of the intracellular level of FDH
activity. Because yeast FDHs in their wild-type forms show
rather low specific activities [28,48]), powerful expression
systems or more active variants of the enzyme [48] should
be employed [7,17,22,24].
Methods
Chemicals and strains
Ethyl 4-cyanobenzoylformate was purchased at Sigma-
Aldrich (Vienna, Austria). Racemic ethyl 4-cyanomande-
late was from Synthon Chemicals GmbH & Co. KG
(Wolfen, Germany). NADH (sodium salt; ≥ 98% pure),
NAD+ (free acid; ≥ 97.5% pure) and NADPH (sodium salt;
≥ 97% pure) were obtained from Roth (Karlsruhe, Ger-
many).
The microorganisms used were E. coli JM109, E. coli BL21
(DE3),  S. cerevisiae CEN.PK 113-7D (MATa MAL2-8c
SUC2) (termed S. c. wild-type) and S. cerevisiae CEN.PK
113-5D (S. cerevisiae CEN.PK 113-7D – URA; MATa
MAL2-8c SUC2 ura3). Pfu  DNA polymerase was from
Promega (Madison, WI, USA). dNTPs, T4 DNA ligase, and
restriction enzymes were from MBI Fermentas (Flambor-
ough, ON, Canada). The ionic liquid 1-butyl-3-methylim-
idazolium hexafluorophosphate (BMIMPF6) was from
Sigma-Aldrich (product number 18122). All other chemi-
cals were purchased from Sigma-Aldrich/Fluka (Gilling-
ham, Dorset, U.K.) or Roth (Karlsruhe, Germany), and
were of the highest purity available.
Strain construction
All DNA manipulations and bacterial transformations
were carried out according to standard protocols. Cloning
of the CbFDH gene (from strain C. boidinii ATCC 18810)
into the plasmid vector pBTac1 (pBTac1-FDH) was
described previously [49]. The strain E. coli JM109 har-
bouring pBTac1-FDH was termed E. coli FDH. The pET-
Duet-1 vector from Novagen (VWR International GmbH,
Vienna Austria) was used for co-expression of the genes
encoding CtXR and CbFDH. This vector contains two mul-
tiple cloning sites, each of which is preceded by a T7 pro-
moter/lac operator and an optimal ribosome binding site
for high level protein expression [50]. The vector also car-
ries a ColE1 replicon, the lacI gene and an ampicillin
resistance gene. The gene encoding CtXR (from C. tenuis
CBS 4435) was amplified from the plasmid pBEAct.1i
Table 4: Effect of varied activity ratio for CtXR and CbFDH during whole cell-catalyzed reduction of 100 mM ethyl 4-
cyanobenzoylformate by a suitable mixture of E. coli XR_FDH and E. coli FDH.
substrate conc. [mM] XR : FDH additive1,2 yield [mM]3/ee [%]4
100 1 : 2 polymyxin B 18/86.1 R
100 1 : 6 polymyxin B 36/74.6 R
100 1 : 20 polymyxin B 62/71.3 R
100 1 : 2 NAD+, polymyxin B 23/66.8 R
100 1 : 6 NAD+, polymyxin B 36/64.7 R
100 1 : 20 NAD+, polymyxin B 64/71.2 R
500 1 : 2 polymyxin B 25/≥ 99.9 R
500 1 : 6 polymyxin B 39/84.6 R
500 1 : 20 polymyxin B 88/73.7 R
500 1 : 2 NAD+, polymyxin B 29/≥ 99.9 R
500 1 : 6 NAD+, polymyxin B 42/85.1 R
500 1 : 20 NAD+, polymyxin B 90/75.5 R
The activity of CtXR was kept constant at 1.4 U/mL throughout.
1 [NAD+] = 490 μM, 2 [polymyxin B sulphate] = 144 μM;3Standard errors ≤ 15%. 4Detection limit of ethyl 4-cyanomandelate is below 0.01 mM.Microbial Cell Factories 2008, 7:37 http://www.microbialcellfactories.com/content/7/1/37
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[51] by a PCR using Pfu DNA polymerase and the follow-
ing pair of oligonucleotide primers which provided PagI
(compatible ends to NcoI) and HindIII restriction sites.
forward primer: 5'- GGTGGTTCATGAGCGCAAGTATCC-
3',
reverse primer: 5'- ACCACCAAGCTTTTAAACGAAGATT-
GGAATG -3'.
These restriction sites were used subsequently to clone the
gene into the first multiple cloning site of pETDuet-1
(NcoI, HindIII), yielding pETDuet-1-XR. The CbFDH gene
was likewise amplified from pBTac1-FDH using the oligo-
nucleotide primers listed below.
forward primer: 5'- GGAATTCCATATGAAGATCGTTTTAG
-3',
reverse primer: 5'- ACCACCCCTAGGTTATTTCTTATCGT-
GTTTAC -3'.
The primers provided NdeI and AvrII restriction sites
which were used subsequently to clone the CbFDH gene
into the second multiple coning site of pETDuet-1-XR,
yielding pETDuet-1-XR_FDH. E. coli Bl21 (DE3) was
transformed with pETDuet-1-XR_FDH using a standard
electroporation method. The correct integration of the
genes for CtXR and CbFDH and the absence of misincor-
porations of nucleotides due to DNA polymerase errors
were verified by sequencing. The resulting strain was
termed E. coli XR_FDH. Construction of the strain S. cere-
visiae XR2μ was described previously [31]. The strain was
derived from S. cerevisiae CEN.PK 113-5D and harbours
the yeast 2μ expression plasmid p426GPD that contains
the gene for CtXR under control of the strong constitutive
glyceraldehyde-3-phosphate dehydrogenase (GPD) pro-
moter.
Cultivation of strains
E. coli strains were grown in 1000 mL baffled shaken flasks
containing 200 mL of LB media supplemented with 115
mg/L ampicillin. A Certomat® BS-1 incubator from Sarto-
rius was used at a constant agitation rate of 120 rpm.
Recombinant protein production used a standard proce-
dure in which cultures were cooled from 37°C to 25°C
when an optical density of 1.1 (± 10%) was reached. Iso-
propylthio-β-D-galactoside (IPTG) was added in a con-
centration of 0.25 or 1.0 mM, and the cultivation time
after induction was 5 or 20 h. Cells were harvested by cen-
trifugation and broken up with the lysis reagent B-Per
(Pierce, Rockford, IL, USA). S. cerevisiae XR2μ was grown
and processed as described recently [31].
Enzyme activity measurements in the cell-free extracts
Reductase and dehydrogenase activities were assayed
spectrophotometrically at 25°C, monitoring the reduc-
tion or oxidation of NAD(P)(H) at 340 nm over a time of
1–5 min. Typically, rates of 0.05 – 0.10 ΔA/min were
measured. One unit of enzyme activity refers to 1 μmol of
NAD(P)(H) consumed per minute. All measurements
were performed with a Beckman DU-800 spectrophotom-
eter using 50 mM potassium phosphate buffer, pH 7.5.
The standard assay for CtXR contained 10 mM ethyl 4-
cyanobenzoylformate and 250 μM NAD(P)H; that for
CbFDH contained 200 mM sodium formate and 2 mM
NAD+. Five % (v/v) ethanol was added to the buffer to
enhance the solubility of ethyl 4-cyanobenzoylformate.
Reactions were always started by the addition of coen-
zyme. Measured rates were corrected for appropriate
blank readings accounting for non-specific oxidation or
reduction of NAD(P)(H) by the cell extracts. Protein con-
centrations were determined with the BCA assay (Pierce)
using bovine serum albumin as a standard. Determina-
tion of the activities of CtXR, ADH, and AlDH in the cell-
free extract of S. cerevisiae was described previously [31].
Enzyme stability measurements
Reaction mixtures (1 mL total volume) containing 40
gCDW/L E. coli XR_FDH and 100 mM ethyl 4-cyanoben-
zoylformate in 100 mM potassium phosphate buffer, pH
7.5, were incubated in 1.5 mL Eppendorf tubes at 30°C.
Tubes were incubated for 0.5, 1, 2, 3 or 4 h. The reaction
mixture was diluted 20-fold with buffer such that no
organic phase (from insoluble substrate) remained, and
cells were then collected by centrifugation. After cell lysis
using B-Per, enzyme activities were assayed as described
above.
Whole-cell bioreduction of ethyl 4-cyanobenzoylformate
Experiments were carried out at 30 (± 1) °C using 2-mL
Eppendorf reaction tubes that were incubated in an end-
over-end rotator (SB3 from Stuart) at 30 rpm. Cells in a
concentration between 5 and 80 gCDW/L were suspended
in 100 mM potassium phosphate buffer, pH 7.5. Ethyl 4-
cyanobenzoylformate is a liquid and was added in a con-
centration between 10 and 500 mM as indicated. Because
the solubility of ethyl 4-cyanobenzoylformate was only
10 mM under the conditions used, reactions with sub-
strate concentrations of > 10 mM, took place in an aque-
ous-organic two-phase system. The concentration of
sodium formate always exceeded that of the ketone sub-
strate by 50 mM (minimum 150 mM). The total reaction
volume was 1 mL, and conversions were started through
addition of substrate. In reactions where a water-immisci-
ble organic co-solvent (ethyl acetate, butyl acetate, hex-
ane) or ionic liquid (BMIMPF6) was used, the substrate
was dissolved in the co-solvent first and added to the
aqueous phase containing the cells in a 1:1 v/v ratio. AMicrobial Cell Factories 2008, 7:37 http://www.microbialcellfactories.com/content/7/1/37
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potassium phosphate buffer solution was used as control
under otherwise identical conditions. 1 mL samples were
taken at certain times, typically every hour, and analyzed
as described under Analytical methods.
Procedures used in whole-cell reductions catalyzed by S.
cerevisiae XR2μ were described in a recent paper [31].
Analytical methods
Samples were diluted with ethanol as required to obtain a
homogeneous liquid phase. Cells were then separated by
centrifugation. The supernatant was analyzed by chiral
HPLC using a LaChrom HPLC system (Merck-Hitachi)
equipped with a reversed phase CHIRALPAK AD-RH col-
umn from Daicel (purchased at VWR International,
Vienna, Austria) and an L-7400 UV-detector. Detection
was at 210 nm. Baseline separation of the R and S anti-
pode in a racemic mixture of ethyl 4-cyanomandelate was
obtained when using acetonitrile and water (20:80, by
volume) as eluent at a flow rate of 0.5 mL/min and a tem-
perature of 40°C. Authentic (relevant) standards were
used for peak identification, and quantification was based
on peak area that was suitably calibrated with standards of
known concentration. Reported yields of product on sub-
strate consumed are always from analytical data because
product isolation (and determination of the overall yield)
was beyond the scope of this study.
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